The Insight Series: AI & Digital Health
“The Insight Series: AI & Digital Health” features industry experts answering key questions to help inform policymakers and the public about how AI is shaping the future of care delivery.…
Digital Health
Learn more about our Digital Health work.
Expanding Service Margins While Protecting Clinical Availability
Join Genpact as they help Medtech Service leaders tackle the margin challenge by transitioning to a Predictive Triage & Guaranteed Uptime model.
AdvaMed® 2025 Membership Has Its Privileges: Advocacy Wins for Medtech Members
AdvaMed® 2025 Membership Has Its Privileges highlights major legislative and regulatory wins delivering millions in savings and new revenue for members.
AdvaMed® Comment Letter to ASTP/ONC: Accelerating AI Adoption in Clinical Care
AdvaMed’s® Comment Letter to ASTP/ONC, outlines concrete policy reforms across FDA oversight, CMS payment pathways, and HIPAA data-sharing rules to accelerate patient access to AI-enabled medical technologies. As AI-enabled medical…
Dexcom’s Jake Leach Named Chair of AdvaMed’s Diabetes Sector
WASHINGTON—AdvaMed, the MedTech Association®, today announced that Jacob “Jake” Leach, President and Chief Executive Officer at Dexcom, will serve as the next chair of theAdvaMed® Diabetes Sector, succeeding Chris Scoggins,…
Heart Month: Why Sleep Apnea Belongs at the Center of Cardiovascular Care
February is American Heart Month—a time to spotlight cardiovascular disease and highlight innovations that can improve patient outcomes. For the medtech community, it’s an opportunity to address persistent gaps in…
AdvaMed® Receives RAPS Accreditation for Medical Device Submissions Workshop Series (February 2026 in Washington, D.C.)
WASHINGTON, D.C.—AdvaMed, the world’s largest trade association representing medical technology innovators, announced that its Medical Device Submissions Workshop Series (February 23-27 in Washington, D.C.) has been officially approved for RAC…
The Insight Series: AI & Digital Health
AdvaMed® Digital Health Tech division member companies include world leaders in developing AI-enabled solutions to improve health and care, from diagnosis to treatment, clinical decision support, and wearables to wellness.…
Honoring Janet E. Trunzo: A Legacy That Shaped Modern Medtech Regulation
After 30 years atAdvaMed®, Janet E. Trunzo, Senior Advisor to the President and Senior Executive Vice President of Technology and Regulatory Affairs, will retire on January 31, 2026. Her tenure…
Why the Health Tech Investment Act Matters: Peter Weems Breaks Down What This Means for Patients
In a new video developed in partnership with Patients Rising, AdvaMed’s Peter Weems, Vice President of Imaging Government Affairs and Policy Strategy, explains why the Health Tech Investment Act is critical to expanding patient…